CymaBay Therapeutics, Inc. reports

Company location: Newark, CA
Fiscal year end: 31 December

CymaBay Therapeutics, Inc. has filed 780 SEC EDGAR filings since 19 Feb 2002

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 26-32 of 32 matching filings.

Per page

25

Current page

2

10-Q File 001-36500

FORM 10-Q

Filing date: 11 Aug 2015
Reporting date: 30 Jun 2015
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-36500

FORM 10-Q

Filing date: 11 May 2015
Reporting date: 31 Mar 2015
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-36500

10-Q

Filing date: 14 Nov 2014
Reporting date: 30 Sep 2014
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-36500

10-Q

Filing date: 14 Aug 2014
Reporting date: 30 Jun 2014
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 000-55021

FORM 10-Q

Filing date: 15 May 2014
Reporting date: 31 Mar 2014
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q/A File 000-55021

AMENDMENT NO. 1 TO FORM 10-Q

Filing date: 16 Dec 2013
Reporting date: 30 Sep 2013
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 000-55021

10-Q

Filing date: 25 Nov 2013
Reporting date: 30 Sep 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .